Metformin reduces ovarian hyperstimulation syndrome risk in polycystic ovary syndrome patients who receive gonadotropins for in-vitro fertilization cycles. A parallel randomized double-blind placebo-controlled clinical trial / Palomba, S.; Falbo, A.; Di Cello, A.; Cappiello, F.; Tolino, Achille; La Sala, G. B.; Zullo, F.; Cittadini, E.. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - STAMPA. - 96:6(2011), pp. 1384-1390.

Metformin reduces ovarian hyperstimulation syndrome risk in polycystic ovary syndrome patients who receive gonadotropins for in-vitro fertilization cycles. A parallel randomized double-blind placebo-controlled clinical trial.

TOLINO, ACHILLE;
2011

2011
Metformin reduces ovarian hyperstimulation syndrome risk in polycystic ovary syndrome patients who receive gonadotropins for in-vitro fertilization cycles. A parallel randomized double-blind placebo-controlled clinical trial / Palomba, S.; Falbo, A.; Di Cello, A.; Cappiello, F.; Tolino, Achille; La Sala, G. B.; Zullo, F.; Cittadini, E.. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - STAMPA. - 96:6(2011), pp. 1384-1390.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/473304
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact